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Introduction
A large array of structurally diverse, and medically important,
bacterially-derived natural products are biosynthesized by
modular polyketide synthases (PKSs).[1–6] These are multifunc-
tional enzymes containing any number of distinct modules re-
sponsible for each successive round of coenzyme A thioester
monomer (typically malonyl or methylmalonyl CoA) decarboxy-
lative condensations into the final polyketide core structure. At
minimum each module contains a ketosynthase (KS), acyltrans-
ferase (AT) catalytic domains as well as an acyl carrier protein
(ACP), to which the polyketide chain is attached. Additionally,
modules can contain a variety of tailoring domains responsible
for catalyzing keto and enoyl group reduction as well as dehy-
dration activities. The pikromycin (Pik) PKS from Streptomyces
venezuelae ATCC 15439 contains six such distinct modules,
which together with a loading module and a termination
domain, are responsible for the formation of the 14-membered
ring macrolide product, narbonolide (early termination without
use of module 6 provides the 12-membered ring macrolide,
10-deoxymethynolide;[7] Figure 1). These two structures are
then modified by glycosylation and hydroxylation to their cor-
responding antibiotics pikromycin and methymycin.[8]
In many PKSs, multiple modules (typically 2–6) can be
housed on a single polypeptide. There are also many PKSs in
which several or even all of the modules are contained on sep-
arate polypeptides. The six extension modules of the pikromy-
cin PKS are housed on a combination of multimodular (PikAI
and PikAII) and monomodular (PikAIII and PikAIV) polypeptides
(Figure 1). In contrast the six extension modules of the 6-de-ACHTUNGTRENNUNGoxyerythronolide B synthase (DEBS) are all housed on threeACHTUNGTRENNUNGbimodular polypeptides.[9]
A short intraprotein linker, typically about 20–30 amino
acids, is responsible for linking modules within multimodular
polypeptides.[10, 11] Much longer docking domains (DDs, ~100
amino acids) are found at the C- and N terminus of both mon-
omodular and multimodular type I PKS polypeptides. The
proper DD interactions have been shown to be essential in
promoting the appropriate protein–protein and thus module–
module interactions required for the biosynthetic process-
es.[12–17] Perhaps the most vital aspect of DD interactions is the
selective binding that discrete DD pairs exhibit for one anoth-
er.
The binding affinities for matched DD pairs from both the
DEBS and Pik PKS systems have been determined by surface
plasmon resonance (SPR), and have shown that these docking
appendages selectively bind to their cognate partners while
mismatched pairs showed no binding.[18] While other protein–
protein interactions between the ACP and KS domains could
play a role in the binding and association of sequential mod-
ules, the specific amino acids involved have not yet beenACHTUNGTRENNUNGdetermined.[19, 20]
The pikromyin polyketide synthase (PKS) in Streptomyces vene-
zulae is comprised of a loading module and six extension mod-
ules, which generate the corresponding 14-membered macro-
lactone product. PikAI is a multimodular component of this
PKS and houses both the loading domain and the first two ex-
tension modules, joined by short intraprotein linkers. We have
shown that PikAI can be separated into two proteins at either
of these linkers, only when matched pairs of docking domains
(DDs) from a heterologous modular phoslactomycin PKS are
used in place of the intraprotein linker. In both cases the yields
of pikromycin produced by the S. venezuelae mutant were
50 % of that of a S. venezuelae strain expressing the native tri-
modular PikAI. This observation provides the first demonstra-
tion that such separations do not dramatically impact the effi-
ciency of the entire in vivo biosynthetic process. Expression of
module 2 as a monomodular protein fused to a heterologous
N-terminal docking domain was also observed to give almost a
tenfold improvement in the in vivo generation of pikromycin
from a synthetic diketide intermediate. These results demon-
strate the utility of DDs to manipulate biosynthetic processes
catalyzed by modular PKSs and the quest to generate novel
polyketide products.
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Both NMR spectroscopy and X-ray crystallographic structural
models of the DD interactions for DEBS2/DEBS3[15] and PikAIII/
PikAIV[18] junctions, respectively, have been reported. Both of
these models depict the DD interactions as being primarily de-
termined by a set of a helices formed by the DD peptide re-
gions. These interactions play a critical role in both the stabili-
zation of the PKS homodimer and the docking interactions of
the C-terminal ACP bound domain with the N-terminal DD of
the subsequent KS.[15, 18] Due to the fact that these DD sequen-
ces tend to be unconserved in nature, classification of theseACHTUNGTRENNUNGinteractions has been limited. However, recently Thattai et al.
have reported an in-depth computational analysis based on
the previously mentioned NMR structural model of the DEBS
DD pair. This work has classified and organized PKS DD pairs
into distinct subclasses, depending on key amino acid residues
making direct interactions.[21]
While the length and structure of intraprotein linkers and
DD is different,[11, 16] their functional role is equivalent; they me-
diate transfer of a growing polyketide chain from the C-termi-
nal ACP of one module to the N-terminal KS of the next
module. This functional equivalency raises the intriguing ques-
tion of whether they can be exchanged without significantly
reducing overall production levels.
Replacement of docking domains with an intraprotein linker
would permit an increase in the number of modules on a poly-
peptide. An increase from dimodular to tetramodular polypep-
tides in the DEBS system has been accomplished by a different
approach of fusing the N- and C-terminal docking domains.[22]
Figure 1. Two routes to prime the pikromycin PKS and provide 12- and 14-membered macrocyclic products. The natural process occurs with the generation
of the enzyme-bound propionate starter unit of the loading domain from methylmalonyl CoA. An alternate less efficient route, which can occur in the ab-
sence of the loading domain and module 1 or mutational inactivation of module 1, is the transfer of the diketide intermediate, (2S)-methyl-(3R)-hydroxypenta-
noic acid (activated as a NAC thioester) onto the KS domain of module 1.
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Other examples of functional PKS polypeptide fusions have
been reported in the aureothin,[23] borrelidin,[24] and rapamy-
cin[25] systems. The fusion of two of the three polypeptides
(DEBS1+2 or DEBS 2+3) together yielded comparable produc-
tion levels, but fusion of all three polypeptides resulted in
barely detectable levels when compared to the wild-type
system.[22] In the aureothin and borrelidin examples, functional
fusion of AurA and BorA5 monomodules with their respective
adjacent PKS polypeptides AurB and BorA4 and or BorA6 pro-
vided evidence of their iterative functionality. In the case ofACHTUNGTRENNUNGrapamycin, the second module of this PKS was fused between
the first and second module of DEBS to produce a small
amount (5 %) of the expected tetraketide product.[25] With the
exception of the DEBS polypeptide fusions these examples
yielded a significant drop in production levels compared to
control experiments with native modules.
Conversely, replacement of intraprotein linkers with a
matched pair of docking domains from a heterologous system
should permit separation of a multimodular polypeptide into
monomodules. Such an experiment has been reported for
both the multimodular components of the rifamycin[26] and
epothilone[27] PKS proteins when these complex pathways
were reconstructed in E. coli. For the epothilone case, EpoD,
which contains four modules, was split into two modules by
using a matched DD pair from the stigmatellin PKS.[27] For the
rifamycin case the tetramodular RifA was split into two pro-
teins by using a matched DD from the erythromycin PKS.[26] In
both cases the yields of the fully extended polyketide products
were very low (10 mg L1 for epothilone C). The multimodular
separation was also needed to address problems with expres-
sion of soluble multimodular PKS component. Therefore, the
effect of multimodular separations on polyketide production in
hosts in which the multimodular PKS is expressed as a soluble
protein is unknown.
We have investigated this question in the pikromycin pro-
ducing Streptomyces venezuelae host using a heterologous DD
pair from the phoslactomycin (Plm) PKS[28] to replace the two
PikAI intraprotein regions that link the loading domain and
first two extension modules. The results show that such sepa-
rations lead to only modest decreases in the overall pikromycin
yields.
Results and Discussion
We employed an experimental approach that was built upon
an established plasmid-based complementation system in
which pDHS722 drives expression of PikAI in BB138—a PikAI
deletion strain of S. venezuelae.[29] Three pDHS722 derivatives
were constructed pJY12, pJY7 and pJY9. In pJY7, the DNAACHTUNGTRENNUNGsequence encoding the intraprotein linker between modules 1
and 2 of PikAI was replaced with a fragment that spans the
region encoding the C-terminal docking domain of Plm1 to
that encoding the N-terminal docking domain of Plm2-3. This
plasmid was designed to express PikAI in which the two exten-
sion modules are now contained on separate polypeptides. A
similar replacement of the DNA sequence encoding the load-
Figure 2. HPLC and LC-MS analysis of methylmycin and pikromycin production. A) Overlaid HPLC trace for fermentations of BB138 carrying the indicated com-
plementation plasmids. B) Selected ion monitoring for the expected macrolide products methymycin and pikromcyin, which eluted at approximately 15 and
21 min, respectively. C) Mass spectra of the products methymycin and pikromycin at m/z 470 and 526 in the positive mode, respectively.
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ing domain–module 1 intraprotein linker in pDHS722 generat-
ed pJY12, which was designed to determine if docking do-
mains can permit the loading domain to function as a separate
polypeptide. In the case of pJY9, the DNA sequence for the in-
traprotein linker between modules 1 and 2 was replaced with
a stop codon, and the start codon (and associated ribosome
binding site) for Plm2-3 expression. This plasmid was designed
to test the effect of separating modules 1 and 2 without using
DDs. In all cases fusion points were based on multiple align-
ments of the KS and ACP domains from multiple PKS systems.
Triplicate liquid fermentations of each S. venezuelae BB138
carrying pDHS722, pJY12, pJY7 or pJY9 were carried out in
order to determine if these three complementation variants
produced the expected macrolide products. Detection and
quantification of methymycin and pikromycin products was
performed by using HPLC analysis combined with UV and MS
(m/z 470 and 526 in positive mode) and confirmed with au-
thentic standards (Figure 2). Production of methymycin and
pikromycin was observed in both BB138/pJY12 and BB138/
pJY7, and the yields were approximately 50 % of that observed
for BB138/pDHS722 (Figure 3). However, in the case of BB138/
pJY9, for which no linker or DD pair was present between
modules 1 and 2, only trace amounts of the polyketide prod-
ucts were detected: <0.1 % compared to intact PikA1
(pDHS722; Figure 3). This dramatic decrease in pikromycin
yields likely indicates that in the separated modules without
DDs, protein recognition between the ACP of module 1 and
the KS of module 2 is not sufficient to permit transfer from
modules 1 to 2. Alternatively, the expression of a soluble sepa-
rate module 2 might be lower without an N-terminal DD pres-
ent. Indeed, work by Khosla et al. on in vitro expression of
an individual PKS monomodule[13, 30–32] and specifically Pik
module 2[33] has shown that an N-terminal stretch of amino
acids (linker or DD) is required for the expression and catalytic
activity of these proteins (the trace levels of pikromycin by
BB138/pJY9 demonstrate some level of expression of this pro-
tein).
There are numerous examples for which it has been demon-
strated that N-acetylcysteamine (NAC) thioesters of polyketide
intermediates can be loaded and processed by KS domains to
a final polyketide product.[34, 35] However, this process is ineffi-
cient relative to priming from the cognate ACP of a previous
module. The successful separation of module 2 of PikAI as a
distinct polypeptide by using the Plm DD pair results in this KS
domain being present at the N terminus rather than the center
of the polypeptide; this permitted us to assess if this change
leads to an increased efficiency in processing of the NAC thio-
ester of the natural diketide intermediate. For this work three
plasmids, pBK51, pBK51* and pJY7* were constructed (Fig-ACHTUNGTRENNUNGure 3). Plasmid pBK51 is a derivative of pDHS722 and expresses
PikAI in which module 1 is catalytically inactive as a result of
the Cys to Ala mutation in the KS active site.[36] Plasmid pBK51*
expresses the same mutated PikAI but as two separate poly-
peptides; this plasmid was generated from pBK51 in a manner
analogous to pJY7 from
pDHS722. The final plasmid,
pJY7*, expressed only module 2
of PikAI with the N-terminal
docking domain of Plm2-3 and
was created by deletion of the
appropriate DNA region in pJY7.
Fermentations of BB138 carry-
ing pBK51, pBK51* or pJY7* did
not produce any detectable
levels of methymycin or pikro-
mycin; this is consistent with
either loss of the loading
domain and module 1 of PikAI,
or mutational inactivation of
module 1. These fermentations
were also performed in the pres-
ence of the NAC thioester of
(2S)-methyl-(3R)-hydroxypenta-
noic acid, the natural diketide
intermediate. Fermentations
were conducted three times;
product yields and standard de-
viations were calculated relative
to those obtained with BB138/
pDHS722 (Figure 2). Levels of
pikromycin production in the
case of BB138/pBK51 were ex-
tremely low, much less than 1 %
of that observed in the control
Figure 3. Levels of pikromycin products made in the BB138 PikAI deletion strain of S. venezuelae with the respec-
tive complementation plasmids. Red blocks indicate the Plm1–Plm2-3 docking domain pair from the phoslacto-
mycin system. Diketide feeding experiments were carried out only with BB138 carrying constructs expressing
PikAI in which module 1 was either inactive (through mutational inactivation of the KS domain, indicated by an
X), absent (pJY7*) or missing the C-terminal DD (pJY9). N/A: not applicable; N/D: not detectable.
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culture. This result is in contrast to experiments that have
demonstrated that for the DEBS PKS, the natural diketide inter-
mediate is able to load onto the second module of a dimodu-
lar polypeptide.[37] This observation with DEBS has been report-
ed in a number of hosts, and we have used BB138/pBK3,[38]
which produces the truncated DEBS PKS triketide lactone prod-
uct, to show that it also functions similarly in S. venezuelae. We
have also shown that feeding the natural triketide intermediate
to either BB138 or BB138/pBK51 gives pikromycin yields of
10 % of that observed for the control.[36] The low levels of pik-
romycin production increased to about 2 % of the control with
BB138/pBK51*; this indicates that a modest improvement in di-
ketide utilization can result from expressing module 2 as a
monomodular polypeptide. Notably, however, a significant in-
crease was seen with BB138/pJY7* in which the pikromycin
yields were about 8 % (Figure S1 a–c in the Supporting Infor-
mation) of the control and comparable to that observed with
feeding the triketide intermediates. Thus, removal of the pre-
ceding module rather than separation of the two modules is
more effective at improving utilization of the diketide inter-
mediate (improvements in utilization of diketides for erythro-
mycin biosynthesis have also been observed upon removal of
module 1 of DEBS).[39] This result could indicate that even as
separate polypeptides the loading domain and module 1
might negatively impact loading of diketide onto module 2. Al-
ternatively, the process could simply be inefficient regardless
of the presence of the preceding module, and the improve-
ments might reflect better expression of the new monomodu-
lar module 2. The efficient utilization of the natural diketide by
a separated module 2 was only observed when there was an
N-terminal docking domain. There was no improvement in the
trace levels of pikromycin made by BB138/pJY9 when grown in
the presence the diketide intermediate; this suggests that that
the separate module 2 without a N-terminal DD is either cata-
lytically impaired or poorly expressed.
Conclusions
In summary, these experiments have provided an additional in
vivo example that a multimodular PKS can be separated into
individual modules by replacing the intrapolypeptide linker
with a heterologous DD pair ; this demonstrates that the sepa-
ration does not work in the absence of the DDs. Furthermore,
the observations demonstrate for the first time that multimod-
ular separation can lead to only a modest decrease in the over-
all production of the final polyketide production. Such dissect-
ed systems make multimodular PKS more amenable for crea-
tion of hybrid PKSs, and potentially, the creation of new poly-
ketide products. However, challenges associated with: 1) the
appropriate molecular recognition between the ACP and KS
domains, and 2) the substrate specificity of the catalytic do-
mains, remain. An alternative approach to generating novel
polyketide products is feeding NAC thioesters of analogues of
polyketide intermediates. This approach also faces the chal-
lenge associated with substrate specificity of the catalytic do-
mains and inefficiencies of loading onto the KS of the appro-
priate module. In the case of PikAI we have shown that the in
vivo utilization of a diketide intermediate by a multimodular
protein is very inefficient, but can be improved significantly by
removal of the preceding modules and expression of the ap-
propriate loading module with an N-terminal docking domain.
Experimental Section
Plasmids, strains and culture conditions : All constructed plasmids
were derivatives of pDHS722, a PikA1 complementation plasmid.
All plasmid manipulations were completed in E. coli hosts. Trans-
formants were cultivated on LB–agar media and plasmids were iso-
lated from LB liquid media, both of which were supplemented
with the appropriate antibiotics.
Variants generated from pDHS722 were transformed into BB138 by
using established protocols,[40] and were cultured on R2YE plates.
Transformants were subsequently grown on SPA agar plates
(50 mg L1 thiostrepton). SCM liquid media was used for fermenta-
tion and propagation of S. venezuelae strains.
DNA manipulation : Variants of pDHS722 were prepared by a
series of PCR reactions and subsequent PCR targeting recombina-
tion crossovers in E. coli, before final transformation into S. vene-
zuelae. DNA sequences encoding the docking domains between
modules 1 and 2 of phoslactomycin (PLM) PKS was PCR amplified
from cosmid 10B4[28] with primers PLMDDF (5’-CTG GGG CAC CTC
GAT TTC GG-3’) + PLMDDR (5’-GTG GTG CTT CGT CTC GGC GT-3’).
The PCR product was gel purified with Qiagen gel extraction kit
and cloned into TOPO TA cloning vector (Invitrogen). The inserts
were verified by sequencing with manufacture supplied M13F and
M13R primers, and construct pJY1 was obtained. The aac(3)IVACHTUNGTRENNUNGresistance marker was amplified from pIJ773[41] by using primers
PlmDD-ApraF (5’-CTG ATG CAG TTC ATC GAC ACC GAG TTG GGG
GAC ATC TGA GTA *TAC GGT TCA TGT GCA GCT CCA TC-3’) +
PlmDD-Apra-R (5’-GAA CAG GGC GCG ACG GGA ACA GGA GTG
GTG GCA GAG GAT GTA *TAC TGT AGG CTG GAG CTG CTT C-3’) ;
bold, italicized sequences represent annealing sites for the antibi-
otic marker and * indicates the location of a unique Bstz17I restric-
tion sites introduced for later removal of this marker. The resulting
PCR product was recombined with pJY1 by using established pro-
cedures.[41] The resulting recombinant plasmid, pJY2, was isolated
with GeneJET Plasmid Miniprep Kit (Fermentas) and confirmed by
sequencing. Construct pJY2 was used as a template to generate
PCR products with the needed 39 nucleotide region complementa-
ry to the desired point of recombination between the linked ACP
and KS domains of PikA1. PCR products for the exchange of DNA
sequences encoding the intramodular linkers between modules 1–
2 and LD–module 1 for that coding for the Plm docking domain
pair, were amplified with primer pairs PikA1F (5’-GTC TTC GAC CAC
CCG ACG CCG CTG GCC CTC GTG TCG CTG CTG GGG CAC CTC
GAT TTC GG-3’) + PikA1R (5’-GGG GTA GCG GCA GCT CAT CGC GAC
GAT CGC GAT CGG ATC GTG GTG CTT CGT CTC GGC GT-3’), and
LDSepF (5’-TTC GAC TTC CCC ACC CCC GAG GCT CTC GCG GAG
CAG CTG CTG GGG CAC CTC GAT TTC GG-3’) + LDsepR (5’-GGG
CAG GCG GCA GGC CAT GCC GAC GAT CGC CAC CGG CTC GTG
GTG CTT CGT CTC GGC GT-3’), respectively; primer sequences in
bold italicized font represent annealing sites on the template pJY2,
and the remaining 5’ region represents the complementary 39 nu-
cleotide region of PikAI used for recombination. PCR products
were introduced into pDHS722 by homologous recombination by
using established protocols.[41] Recombinant pDHS722 plasmids,
were isolated as before, treated with Bstz71I to remove the apra
marker, ligated, overnight, at 12 8C, transformed into E. coli and
single colonies screened for both (+)Amp and ()Apra; this yield-
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ed pJY7 and pJY12, respectively. Plasmid pJY9, which had the
region encoding the intrapolypeptide linker between modules 1
and 2 deleted, was also generated by homologous recombination
by using established protocols.[41] The aac(3)IV resistance marker
amplified from pIJ773 was used to delete the linker-encoding
region with primers Pik linkDF (5’-GTC TTC GAC CAC CCG ACG CCG
CTG GCC CTC GTG TCG CTG TGA GTA* TAC GGT TCA TGT GCA
GCT CCA TC-3’) + Pik linkDR (5’-GGG GTA GCG GCA GCT CAT CGC
GAC GAT CGC GAT CGG ATC CAC CTA TCG GCT TCG CGG CTG TCC
GCC CGG TA*T ACT GTA GGC TGG AGC TGC TTC-3’). Bold and itali-
cized sequences represent annealing regions for the resistance
marker, and * indicates the location of the unique the Bstz17I re-
striction sites introduced for later removal of this marker. A TGA
stop codon (underlined and bold) was introduced at the 3’ end of
the module 1 ACP-encoding region in the forward primer. The re-
verse primer contained the complementary sequence to the puta-
tive ribosome binding site (underlined) and start codon (CAC) of
the N-terminal Plm DD (underlined and bold) fused to the begin-
ning of the KS module 2 encoding region. This PCR product was
again recombined into pDHS722 by using established protocols,[41]
the aac(3)IV resistance marker was removed by restriction enzyme
digestion as before, and religated to yield the final pJY9 plasmid.
PBK51* was generated in the exact same manner as pJY7, but by
using pBK51, which encodes PikAI with a Cys to Ala mutation on
KS1, as the final recombination plasmid. Plasmid pJY7*, which ex-
presses only module 2 of PikAI, was generated from pJY7 by using
the PCR-targeted Streptomyces gene replacement method.[41] For
this, the DNA encoding the polypeptide containing just the load-
ing domain and module 1 in pJY7 was replaced with the kanamy-
cin resistance marker. This marker was amplified from pKD13[42]
with primers PikA1scarF (5’-GTT GGG TGA AAG CGC GGC TTC CGG
AGA CGG AGC CGG ATG ATT CCG GGG ATC CGT CGA CC-3’) + Pi-
kAlscarR (5’-GCG ACG GGA ACA GGG GTG GTG GCA GAG GAT GTA
TAC TCA TGT AGG CTG GAG CTG CTT C-3’) ; bold sequences repre-
sent annealing sites for the antibiotic marker, and the remaining
5’ regions represent recombination crossover sites. Successful re-
placement in pJY7 was followed by FLP-mediated excision of the
marker region to generate pJY7*, which encodes PikAI module 2
with the C-terminal docking domain of Plm2-3 at the N terminus.
Polyketide production analysis : SCM media fermentations
(50 mg L1 thiostrepton) were carried out at 30 8C with agitation
(220 rpm) for 72 h. After fermentation the medium was separated
by centrifugation at 11 000 g for 10 min. The fermentation media
was extracted 3  with ethyl acetate (10 mL), dried and resuspend-
ed in MeOH (1 mL). Extracts of BB138/(pJY7, pJY12, pJY9, pBK51,
pBK51*, pJY7*) were analyzed by reverse phase HPLC by using an
Agilent 1100 series system with a 5 mm Discovery HS C18 reversed-
phase column (25  4.6 cm, Supelco), a linear gradient system from
solvent A (20:80 acetonitrile/water and 10 mm ammonium acetate)
to solvent B (80:20 acetonitrile/water and 10 mm ammonium ace-
tate) over 50 min at a flow rate of 1 mL min1, and detection at
220 nm. Relative amounts were determined by integrating and
averaging the peak areas for pikromycin produced in three sepa-
rate extracts and comparison to extracts of BB138/pDHS722 (Fig-
ure 2 A). Extracts were also analyzed by LC-MS to correlate theACHTUNGTRENNUNGobserved retention times with the appropriate masses for both
methymycin and pikromycin (Figure 2 B). LC-MS analysis was car-
ried out with extracts (20 mL) under the same solvent system con-
ditions at a rate of 0.3 mL min1 with a Surevor HPLC system
(Thermo ACHTUNGTRENNUNGFinnigan) connected to a diode array detector equipped
with a 2.1 mm Discovery HS C18 reversed-phase column (25 
4.6 cm Supleco). Mass spectra were collected by using an LCQ
quadrupole ion trap (ThermoFinnigan) mass spectrometer
equipped with an electrospray ion source in positive mode.
Diketide feeding experiments were completed by using an over-
night seed culture to seed fresh SCM (10 mL) fermentations. After
agitation for 10 h under the above-mentioned conditions, the dike-
tide was added from a stock in MeOH to a final concentration of
1 mm—MeOH was used a negative control—and the fermentation
process was permitted to continue for approximately 60 h. Analy-
ses were carried out as described above.
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